DNA Print Genomics Profit Margin

DNA Print Genomics posts a profit margin of -235.64% as of September 2007. That compares with -588.9% in the prior-year period — up 60.0% year over year. That is below the Healthcare sector average of 9.48%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, DNA Print Genomics's profit margin was -588.9%. The latest reading is -235.64% — a 60.0% year-over-year increase (period ending September 2007). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 9.48% is typical. DNA Print Genomics's -235.64% is lower that level. That is roughly 2585.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

DNA Print Genomics's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -235.64% as of September 2007; use YoY and peer views to separate noise from signal.

Context for DNAG's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 9.48%), and (3) consistency with growth and profitability. This page covers the first two; DNA Print Genomics's other metric pages and overview cover the third.